TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
DYN

Dyne Therapeutics Inc

Healthcare · Biotechnology

15.80$ -1.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement DYN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% – – – – – – – –
78.1% 240.9% 167.0% 579.4% – – – – – – – –
21.9% -140.9% -67.0% -479.4% – – – – – – – –
6.6% 15.2% 11.8% 37.4% – – – – – – – –
-21.0% 15.2% 11.8% 37.4% – – – – – – – –
-21.7% 7.6% -46.9% -81.4% – – – – – – – –
4.6% 64.8% 45.8% 121.7% – – – – – – – –
-18.3% -50.7% -94.4% -106.3% – – – – – – – –
8.0% -56.3% -3.3% -120.6% – – – – – – – –
-4.6% 5.9% -90.8% 15.0% – – – – – – – –
19.9% 87.4% 7.8% 187.5% – – – – – – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?